Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Next
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Mar 15, 2021 11:56am
RE:RE:RE:RE:RE:RE:Quiet Board
Stocker46, I know it hurts. It hurts a lot. I'm sorry my friend. I'm sorry that you bought CPH above C$10 a few years ago and you sold it well below C$10, according to your own previous
...more
(78)
•••
Stocker46
X
View Profile
View Bullboard History
Comment by
Stocker46
on Mar 15, 2021 11:10am
RE:RE:RE:RE:RE:Quiet Board
NEWS FLASH stockfy - the idea of investing in the stock market is to buy low & sell high. Already stated I believe the SP could go significantly higher. Unfortunately, this Trulance fiasco is a
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Mar 15, 2021 10:04am
RE:CPH at 1.5x its EBITDA, Facts About Absorica And More
Some new aliaes have joined the board lately out of nowhere. They smelled the blood and CPH's extremely low valuation, so they desperately try to make the weak hands sell at 90 cents by posting
...more
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Mar 15, 2021 10:01am
RE:RE:RE:CPH's Hospital Products: Deal with Verity -> Revenue Growth
Contact the company. I have already done my dd and it's not for free.
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Mar 15, 2021 10:00am
RE:RE:RE:RE:CPH repurchased at C$1.14 and Employees bought at C$1.05
Read the quarterly reports and/or contact the company. I post facts.
(11)
•••
r0nald
X
View Profile
View Bullboard History
Comment by
r0nald
on Mar 15, 2021 8:21am
RE:RE:RE:RE:RE:Quiet Board
I really don't like having lost an arbitration case that we couldn't loose. But really dislike not knowing how much we're going to have to pay Bausch. What if they want compensation for
...more
(189)
•••
faraj69
X
View Profile
View Bullboard History
Comment by
faraj69
on Mar 15, 2021 8:17am
RE:RE:RE:RE:RE:Quiet Board
Lmao Pablo has been a CPH advocate for years. Guy knows more about the company than anyone on this bb. There's NO DEMAND for this stock even with a low share float of 21 mill.
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Mar 15, 2021 5:12am
RE:RE:RE:RE:Quiet Board
Look Stocker46, you are not the smart of the board. We do not need your confirmation. We do know that it's correct. We do know that it's a non-cash impairment charge although the clueless
...more
(78)
•••
Stocker46
X
View Profile
View Bullboard History
Comment by
Stocker46
on Mar 14, 2021 12:57pm
RE:RE:RE:Quiet Board
Correct, the impairment charge is a non-cash entry. It's kind of like spending $8 - $ 9 million on a fixed asset to be amortized over 15 or 20 years. Then you find out a year & a half
...more
(1)
•••
maxxie3
X
View Profile
View Bullboard History
Comment by
maxxie3
on Mar 12, 2021 3:35pm
RE:RE:Quiet Board
It is a non cash charge so it would not impact cash flow it would reduce the net earnings it will be interesting to see how the market see it. I think everyone dump shares already.
(1)
•••
GJS471
X
View Profile
View Bullboard History
Comment by
GJS471
on Mar 12, 2021 1:50pm
RE:Quiet Board
In some ways, the quiet board is a nice change. Lately there has been lots of questionable opinions, lopsided analysis and only occassionally something of value. In any case, I
...more
(189)
•••
faraj69
X
View Profile
View Bullboard History
Comment by
faraj69
on Mar 12, 2021 11:24am
RE:Earnings
Happy to see you've woken up Pablo. Go put money into FCO and you can thank me later.
(28)
•••
pabaloo
X
View Profile
View Bullboard History
Post by
pabaloo
on Mar 12, 2021 11:14am
Earnings
Keeping an eye on weather revenue has started to ramp down yet? Every report has the revenue falling off a cliff after this December.
(78)
•••
Stocker46
X
View Profile
View Bullboard History
Post by
Stocker46
on Mar 09, 2021 3:52pm
Quiet Board
Very interested in seeing Cipher's 4th Quarter/Annual Financials that will likely be released next week. Highly probable they booked the $5.4M US impairment charge in 4th quarter while the $240
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden